“…Many functions have been described for RTEF-1, including enhancement of the promoter activity of VEGF (Shie et al ., 2004) and hypoxia-inducible factor-1α (HIF-1α) (Jin, 2011) under hypoxia, increased angiogenesis in the hindlimb ischaemia model (Shie et al ., 2004; Jin, 2011), facilitation of communication between the endothelium and myocardium (Xu et al ., 2011), enhancement of endothelial-dependent microvascular relaxation (Messmer-Blust et al ., 2012a), regulation of cell-to-cell connections and aggregation via connexin 43, connexin 40, and connexin 37 (An et al ., 2012) and attenuation of blood glucose levels through insulin-like growth factor binding protein-1 (IGFBP1) regulation in ECs (Messmer-Blust et al ., 2012b). We hypothesized that RTEF-1 may be impaired during aging, as it serves as a regulatory factor during angiogenesis progression.…”